|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_ocn991595808 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170626s2017 nyu ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d EBLCP
|d OCLCF
|d AGLDB
|d IGB
|d AUW
|d BTN
|d MHW
|d INTCL
|d SNK
|d YDX
|d G3B
|d S8I
|d S8J
|d STF
|d D6H
|d N$T
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781536119589
|q (electronic bk.)
|
| 020 |
|
|
|a 153611958X
|q (electronic bk.)
|
| 020 |
|
|
|z 9781536119381
|
| 035 |
|
|
|a (OCoLC)991595808
|
| 050 |
|
4 |
|a RM315
|
| 072 |
|
7 |
|a MED
|x 105020
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.788
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Psychotropic drugs and medical conditions /
|c Faruk Uguz, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2017]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Psychiatry, theory, applications and treatments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed June 27, 2017)
|
| 505 |
0 |
|
|a Preface; Acknowledgments; Chapter 1; Hematological Effects of Psychotropic Medications; Abstract; Introduction; Antipsychotic Medications; Second Generation Antipsychotic Drugs; Clozapine; Olanzapine; Risperidone and Paliperidone: Short-Acting and Long-Acting; Quetiapine; Ziprasidone; Aripiprazole; Iloperidone, Asenapine, and Lurasidone; First Generation Antipsychotic Drugs; Phenothiazines; Butyrophenones; Mood Stabilizer Medications; Carbamazepine; Oxcarbazepine; Divalproex; Lamotrigine; Lithium; Gabapentin; Pregabalin; Topiramate; Antidepressant Drugs
|
| 505 |
8 |
|
|a Selective Serotonin Reuptake InhibitorsBupropion; Selective Serotonin Norepinephrine Reuptake Inhibitors; Atypical Antidepressants; Tricyclic and Tetracyclic Antidepressants; Benzodiazepines; Buspirone; Management; Conclusion; References; Chapter 2; Psychotropic Drug-Induced Renal Toxicity and Electrolyte Imbalance; Abstract; Introduction; Role of Kidneys in Drug Metabolism and Homeostasis; Psychotropics Known to Cause Renal Impairment and Electrolyte Imbalance; Psychotropics Causing Renal Toxicity; Lithium; Reduced Urinary Concentrating Capacity; Effect on Glomerular Filtration Rate
|
| 505 |
8 |
|
|a Development of Nephrogenic Diabetes Insipidus (NDI)Other Renal Effects of Lithium; Antidepressants; Antipsychotics; Psychotropics Causing Electrolyte Imbalance; Psychotropic-Induced Hyponatremia (Table 3); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hypernatremia (Table 4); Psychotropic-Induced Hypokalemia (Table 4); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hyperkalemia (Table 4); Psychotropic-Induced Hypocalcemia (Table 4); Psychotropic-Induced Hypercalcemia (Table 4)
|
| 505 |
8 |
|
|a Risk Factors of Psychotropic Induced Renal Impairment and Electrolyte ImbalanceAge; Gender; Physical Health and Co-Morbid Physical Illness; History of Hyponatremia/Electrolyte Disturbances in the Past; Nature of Psychiatry Disorder; Use of Other Concomitant Medications; Dose of Psychotropic Drug Used; Duration of Treatment; How to Prevent?; Psychotropic-Induced Renal Impairment; Psychotropic-induced Electrolyte Imbalance; Management; Management of Psychotropic-induced Renal Impairment Due to Rhabdomyolysis; Management of Lithium-induced Nephrogenic Diabetes Insipidus (NDI)
|
| 505 |
8 |
|
|a Management of Lithium-Induced NephropathyTreatment of Lithium Toxicity and When to Go for Dialysis?; Psychotropic-Induced Electrolyte Imbalances; Hyponatremia; Management of Other Psychotropic-induced Electrolyte Imbalances; Conclusion; References; Chapter 3; Psychotropic Drug-Induced Hepatotoxicity; Abstract; Introduction; Antidepressants; Monoamine Oxidase (MAO) Inhibitors; Tricyclic Antidepressants; Selective Serotonin Reuptake Inhibitors; Serotonin Noradrenaline Reuptake Inhibitors; New Generation Antidepressants; Antipsychotic Agents; First Generation Antipsychotics (FGAs)
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Psychotropic drugs.
|
| 650 |
|
2 |
|a Psychotropic Drugs
|
| 650 |
|
6 |
|a Psychotropes.
|
| 650 |
|
7 |
|a MEDICAL
|x Psychiatry
|x Psychopharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Psychotropic drugs.
|2 fast
|0 (OCoLC)fst01081826
|
| 700 |
1 |
|
|a Uguz, Faruk,
|e editor.
|
| 830 |
|
0 |
|a Psychiatry- theory, applications, and treatments series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1540037
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4882736
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1540037
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 14263210
|
| 994 |
|
|
|a 92
|b IZTAP
|
